Posts

Clinical Trials: Collaboration is the Secret to Successful Outsourcing. http://bit.ly/2nPAAYD

bit.ly
bit.ly

Macrophages are now widely classified as M1 or M2 rather than the organ-specific names assigned in the past. Learn more about the M1 and M2 classifications here. http://bit.ly/2ENCFvn

The Difference Between M1 & M2 Macrophages | Astarte Biologics
Macrophages are a diverse group of white blood cells known for eliminating pathogens through phagocytosis. Learn more about the M1 and M2 classifications.
astartebio.com
See All
Reviews
Astarte Biologics has no reviews yet.
Tell people what you think
See All
Videos
We’ve made it easier than ever to find the exact cells and donors you need. Check out our newly improved product filters and search functionality. Give it a try! http://bit.ly/2v205uH
1
Get free shipping on your first order when you create a new online account. Take 1 minute to create an account and enjoy the savings! http://bit.ly/2gqiqsI
Struggling to find the exact immune cell products, specifications, or donors you need? We've made it easier than ever to filter, sort, and find immune cell products to match your requirements. Give it a try! http://bit.ly/2wq1EQb #pbmc #tcells #immunology #research
See All
Photos
Image may contain: one or more people and text
No automatic alt text available.
Image may contain: one or more people and text
See All
Posts

Gene Therapy News: FDA Approves First In Vivo Treatment http://bit.ly/2DPiwE6

FDA Approves In Vivo Gene Therapy | Astarte Biologics
Luxturna was recently approved by the FDA for the treatment of patients with blindness. This approval is monumental for the entire medical field. Learn more!
astartebio.com

Last day at #SLAS2018! What are your plans for today? We'll be in booth 1652 answering your #immunecell and #research questions!

Image may contain: one or more people and text

Live from #SLAS2018: #3Dcellculture is gaining traction with more automation addressing this approach. For many cell types, the architecture is critical to function or cell behavior.

Good morning #SLAS2018! Who needs coffee? Come to booth 1652 today to connect with a scientist and your next coffee is our gift!

No automatic alt text available.

Have coffee with a scientist! Stop by #SLAS2018 booth 1652 to #AskAScientist a question and your next Starbucks drink is on us!

Image may contain: one or more people and text

Welcome to #SLAS2018! Come see us tomorrow at booth 1652 to discuss everything immune cells: products, research services, protocols, and FAQs.

Image may contain: text

Looking forward to #SLAS2018! What events are you attending? We'll be answering questions at booth 1652. Stop by to #AskAScientist!

No automatic alt text available.

The first in vivo gene therapy, Luxturna, was recently approved by the FDA. This treatment is monumental for the entire medical field. Learn more! http://bit.ly/2DPiwE6

FDA Approves In Vivo Gene Therapy | Astarte Biologics
Luxturna was recently approved by the FDA for the treatment of patients with blindness. This approval is monumental for the entire medical field. Learn more!
astartebio.com

While CAR-T therapies could vastly improve outcomes in some types of blood cancer, finding ways to replicate this effectively and safely in solid tumors remains a challenge. http://bit.ly/2nryCg5

New approaches could crack CAR-T solid tumour challenge - Pharmaphorum
There could be ways to improve effectiveness of CAR-T therapy by improving classification of tumours, and pre-treating them to remove obstacles that prevent an immune response.
pharmaphorum.com

How can pharma and regulators address the rising prices of new oncology treatments while still promoting R&D? http://bit.ly/2rVO4qv

Balancing cost:benefit in ‘well-treated’ malignancies - Pharmaphorum
The cost: benefit ratio of the rising prices of new oncology treatments and how the pharmaceutical industry and regulators can adequately address them.
pharmaphorum.com

Ask A Scientist: What’s the Difference Between Primary and Immortalized Cells? http://bit.ly/2rkJdia

Comparing Primary & Immortalized Cells | Astarte Biologics
Primary and immortalized cells have different characteristics, functions, and use cases. Learn the main differences and best cells to use in your research.
astartebio.com

Ask A Scientist: What’s the Difference Between Human Monocytes and Macrophages? http://bit.ly/2DikD76

Difference Between Monocytes and Macrophages | Astarte Biologics
Monocytes & macrophages are very closely related cells with a few distinctions. Monocytes are macrophages in the blood. Macrophages are monocytes in tissue.
astartebio.com

Celgene to Buy Juno Therapeutics for $9 Billion http://on.wsj.com/2n4Myx7

Celgene to Buy Juno Therapeutics for $9 Billion
Celgene said it agreed to buy Juno Therapeutics for $87 a share in cash, or about $9 billion, in a move that will expand Celgene’s portfolio of blood-cancer drugs.
wsj.com